ATE527341T1 - Hepatische differenzierung von stammzellen - Google Patents

Hepatische differenzierung von stammzellen

Info

Publication number
ATE527341T1
ATE527341T1 AT04822334T AT04822334T ATE527341T1 AT E527341 T1 ATE527341 T1 AT E527341T1 AT 04822334 T AT04822334 T AT 04822334T AT 04822334 T AT04822334 T AT 04822334T AT E527341 T1 ATE527341 T1 AT E527341T1
Authority
AT
Austria
Prior art keywords
stem cells
hepatic differentiation
disclosed
methods
differentiation
Prior art date
Application number
AT04822334T
Other languages
English (en)
Inventor
Vera Rogiers
Tamara Vanhaecke
Sarah Snykers
Peggy Papeleu
Matthieu Vinken
Tom Henkens
Greetje Elaut
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Application granted granted Critical
Publication of ATE527341T1 publication Critical patent/ATE527341T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04822334T 2004-10-27 2004-10-27 Hepatische differenzierung von stammzellen ATE527341T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/012134 WO2006045331A1 (en) 2004-10-27 2004-10-27 Differentiation of stem cells and stabilization of phenotypical properties of primary cells

Publications (1)

Publication Number Publication Date
ATE527341T1 true ATE527341T1 (de) 2011-10-15

Family

ID=34959404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04822334T ATE527341T1 (de) 2004-10-27 2004-10-27 Hepatische differenzierung von stammzellen

Country Status (4)

Country Link
US (1) US20090130064A1 (de)
EP (1) EP1824965B1 (de)
AT (1) ATE527341T1 (de)
WO (1) WO2006045331A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278782A1 (en) * 2006-06-12 2010-11-04 Vrije Universiteit Brussel Differentiation of rat liver epithelial cells into hepatocyte-like cells
US20100196929A1 (en) * 2007-06-01 2010-08-05 Vrije Universiteit Brussel Stabilisation of the phenotypic properties of isolated primary cells
EP2245140A2 (de) * 2007-11-30 2010-11-03 New York Medical College Zusammensetzungen mit hdac-inhibitoren und verfahren zu deren verwendung bei der wiederherstellung der stammzellenfunktion und vorbeugung von herzversagen
AU2008334036B2 (en) 2007-11-30 2014-05-29 New York Medical College Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
EP2227238A2 (de) 2007-11-30 2010-09-15 New York Medical College Zusammensetzungen mit vaskulären und myozyten-vorläuferzellen und anwendungsverfahren davon
ES2862623T3 (es) * 2008-05-22 2021-10-07 Vesta Therapeutics Inc Método de diferenciación de células progenitoras de mamíferos en células pancreáticas de los islotes productoras de insulina
CA2796251C (en) * 2010-04-13 2019-05-14 Cellular Dynamics International, Inc. Hepatocyte production by forward programming
WO2012006440A2 (en) 2010-07-07 2012-01-12 Cellular Dynamics International, Inc. Endothelial cell production by programming
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
KR101697437B1 (ko) * 2015-10-12 2017-01-17 전남대학교병원 중간엽줄기세포의 심근유사세포 분화유도용 아피시딘 함유 조성물
KR102757122B1 (ko) 2015-10-20 2025-01-21 셀퀴티 인크. 1차 세포 샘플을 제조하는 방법
KR101879517B1 (ko) * 2016-12-27 2018-07-17 전남대학교병원 중간엽 줄기세포를 심근세포로 분화시키는 방법
CN109609443B (zh) * 2019-01-14 2022-07-05 上海银海圣生物科技有限公司 一种小鼠肝脏原代细胞培养基、培养方法及培养箱
EP4408169A4 (de) * 2021-09-30 2025-10-29 Univ Southern California Humanes hepatozytenkulturmedium und konditioniertes medium aus in-vitro kultivierten humanen hepatozyten und verwendungen davon
CN118858493B (zh) * 2024-09-23 2024-12-03 成都市食品检验研究院 固相萃取-超高效液相色谱-串联质谱法检测蜂蜜中植物源性毒素的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346152A1 (en) * 1998-10-16 2000-04-27 Novartis Ag Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors
WO2002064748A2 (en) * 2001-02-14 2002-08-22 Furcht Leo T Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
EP1176189A1 (de) * 2000-07-21 2002-01-30 Fornix Biosciences N.V. Stammzellen-änhliche Zellen
WO2004046312A2 (en) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
WO2004087896A2 (en) * 2003-03-31 2004-10-14 Pfizer Products Inc. Hepatocyte differentiation of stem cells
US7332336B2 (en) * 2003-08-19 2008-02-19 Effector Cell Institute, Inc. Methods for inducing differentiation of pluripotent cells

Also Published As

Publication number Publication date
EP1824965A1 (de) 2007-08-29
US20090130064A1 (en) 2009-05-21
WO2006045331A1 (en) 2006-05-04
EP1824965B1 (de) 2011-10-05

Similar Documents

Publication Publication Date Title
ATE527341T1 (de) Hepatische differenzierung von stammzellen
ATE530636T1 (de) Zellkultur
GB2446525A (en) Stem cell culture medium and method
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
WO2006015209A3 (en) Differentiation of stem cells
DK2638064T3 (da) Celledyrkningsmedie og fremgangsmåde til proteinekspression, hvilket medie og hvilken fremgangsmåde omfatter en PAM inhibitor
ATE476940T1 (de) Gerät zur wiederherstellung der aortenklappe und dieses verwendende behandlungsverfahren
ATE463490T1 (de) Histondeacetylase-hemmer
NO20032465D0 (no) Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
NO20075229L (no) N-hydroksyamider omega-substituert med trisykliske grupper som histondeacetylasehemmere, deres fremstilling og anvendelse i farmasoytiske formuleringer
SG196784A1 (en) Stem cell cultures
WO2007025247A3 (en) Transglutaminase inhibitors and methods of use thereof
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20072005L (no) Nye heterocykliske amider
WO2004043348A3 (en) Histone deacetylase inhibitors for treating degenerative diseases of the eye
DK1720550T3 (da) Derivater af piperidinylalkylcarbamater, fremstilling heraf samt anvendelse heraf som inhibitorer for FAAH enzym
IS7756A (is) Aðferðir til að auka framleiðslu blóðflögu- og blóðmyndandi stofnfrumna
NO20045675L (no) Peptiddeformylaseinhibitorer
DE602007010819D1 (de) Verringerung von übergewicht oder fettsucht
WO2003080649A3 (en) Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
WO2009076234A3 (en) Synthesis methods of histone deacetylase inhibitors (hdacis)
WO2011064549A3 (en) Composition and method for differentiation of human embryonic stem cells
DK1709018T3 (da) Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere
WO2020197059A3 (ko) 엽산, 엽산 유도체, 또는 엽산 저해제를 이용한 줄기세포의 연골세포로의 분화 유도 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties